RPRX
Price
$36.53
Change
-$0.13 (-0.35%)
Updated
Sep 4, 02:36 PM (EDT)
Capitalization
15.86B
62 days until earnings call
SANA
Price
$2.87
Change
-$0.12 (-4.01%)
Updated
Sep 4, 02:37 PM (EDT)
Capitalization
760.41M
62 days until earnings call
Interact to see
Advertisement

RPRX vs SANA

Header iconRPRX vs SANA Comparison
Open Charts RPRX vs SANABanner chart's image
Royalty Pharma
Price$36.53
Change-$0.13 (-0.35%)
Volume$2.67K
Capitalization15.86B
Sana Biotechnology
Price$2.87
Change-$0.12 (-4.01%)
Volume$5.2K
Capitalization760.41M
RPRX vs SANA Comparison Chart in %
Loading...
RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RPRX vs. SANA commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPRX is a Hold and SANA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (RPRX: $36.66 vs. SANA: $2.99)
Brand notoriety: RPRX and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RPRX: 188% vs. SANA: 68%
Market capitalization -- RPRX: $15.86B vs. SANA: $760.41M
RPRX [@Biotechnology] is valued at $15.86B. SANA’s [@Biotechnology] market capitalization is $760.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RPRX’s FA Score shows that 1 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • RPRX’s FA Score: 1 green, 4 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, both RPRX and SANA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RPRX’s TA Score shows that 5 TA indicator(s) are bullish while SANA’s TA Score has 4 bullish TA indicator(s).

  • RPRX’s TA Score: 5 bullish, 4 bearish.
  • SANA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, RPRX is a better buy in the short-term than SANA.

Price Growth

RPRX (@Biotechnology) experienced а +1.66% price change this week, while SANA (@Biotechnology) price change was -11.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.71%. For the same industry, the average monthly price growth was +5.90%, and the average quarterly price growth was +27.78%.

Reported Earning Dates

RPRX is expected to report earnings on Nov 05, 2025.

SANA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (-0.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RPRX($15.9B) has a higher market cap than SANA($760M). SANA YTD gains are higher at: 83.436 vs. RPRX (46.514). SANA has less debt than RPRX: SANA (85.5M) vs RPRX (8B).
RPRXSANARPRX / SANA
Capitalization15.9B760M2,092%
EBITDAN/A-197.36M-
Gain YTD46.51483.43656%
P/E Ratio16.02N/A-
RevenueN/A0-
Total CashN/A72.7M-
Total Debt8B85.5M9,359%
FUNDAMENTALS RATINGS
RPRX: Fundamental Ratings
RPRX
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
72
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RPRXSANA
RSI
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
47%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 7 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 15 days ago
77%
Declines
ODDS (%)
Bearish Trend 10 days ago
61%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGPMX39.650.36
+0.92%
Franklin Gold and Precious Metals R6
GGGCX51.290.29
+0.57%
Gabelli Global Growth C
PAGSX67.920.27
+0.40%
T. Rowe Price Global Stock Adv
BPSIX27.96N/A
N/A
Boston Partners Small Cap Value II I
FTMSX26.64-0.07
-0.26%
FullerThaler Behvrl Mcr-Cp Eq Instl

RPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPRX has been loosely correlated with SANA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if RPRX jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPRX
1D Price
Change %
RPRX100%
+1.35%
SANA - RPRX
40%
Loosely correlated
+5.28%
PHIO - RPRX
39%
Loosely correlated
-1.89%
GLPG - RPRX
33%
Loosely correlated
+0.32%
SEER - RPRX
33%
Loosely correlated
-0.98%
XNCR - RPRX
31%
Poorly correlated
-2.57%
More

SANA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SANA has been loosely correlated with VIR. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if SANA jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SANA
1D Price
Change %
SANA100%
+5.28%
VIR - SANA
64%
Loosely correlated
+10.20%
CPRX - SANA
47%
Loosely correlated
-3.65%
RPRX - SANA
40%
Loosely correlated
+1.35%
GBIO - SANA
39%
Loosely correlated
N/A
ABSI - SANA
36%
Loosely correlated
+1.71%
More